Delpharm – a leading CDMO

Delpharm is one of the world’s leading CDMOs, specialising in the development and manufacture of medicines for the pharmaceutical industry. With a network of plants in Europe and North America, the group is firmly positioned among the top five international CDMOs.

Our expertise covers solid, sterile, semi-solid and liquid forms, serving a constant ambition: to support our partners in providing safe, effective and high-quality therapeutic solutions.

Development Production

18

Manufacturing sites

3

Development centers

1.1

Turnover billion €

5

World Top 5

6,500

Headcount

Focus on nasal spray

Delpharm offers comprehensive expertise in the manufacture of nasal sprays: production of batches ranging from 10 to 5,000 litres and filling of 3 to 100 ml glass or plastic bottles, with automated lines and rigorous controls to guarantee quality and compliance with international standards.

Several sites (Montreal, Bladel, Huningue, Orléans) offer flexibility, significant capacity and diverse packaging options, allowing production to be tailored to the needs of pharmaceutical customers.

Find out more on nasal spray production